Published in Gastroenterology on January 01, 1997
Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. J Clin Invest (2009) 1.90
TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest (2002) 1.63
Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med (2009) 1.52
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest (1999) 1.45
Topical review. Gastrin and gastric epithelial physiology. J Physiol (1999) 1.28
Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol (2009) 1.12
Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression. Biochem J (2002) 1.11
Mouse models of gastric cancer. Cancers (Basel) (2013) 1.07
CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis. Gut (2014) 1.03
Retracted Overexpression of pre-pro-cholecystokinin stimulates beta-cell proliferation in mouse and human islets with retention of islet function. Mol Endocrinol (2008) 0.99
Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J Clin Invest (2000) 0.96
Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases. Curr Top Med Chem (2007) 0.95
Requirement of the tissue-restricted homeodomain transcription factor Nkx6.3 in differentiation of gastrin-producing G cells in the stomach antrum. Mol Cell Biol (2008) 0.94
Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis. Am J Physiol Gastrointest Liver Physiol (2012) 0.92
A clinicopathological study of gastric stump carcinoma following proximal gastrectomy. Gastric Cancer (2009) 0.92
Gastric Helicobacter infection induces iron deficiency in the INS-GAS mouse. PLoS One (2012) 0.92
Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival. Endocrinology (2010) 0.91
Expression of gastrin and its receptor in human gastric cancer tissues. J Cancer Res Clin Oncol (2005) 0.91
Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa. J Clin Invest (2000) 0.90
Gastric acid secretion in aquaporin-4 knockout mice. Am J Physiol Gastrointest Liver Physiol (2000) 0.89
Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy. Proc Natl Acad Sci U S A (1997) 0.89
Decreased gastric bacterial killing and up-regulation of protective genes in small intestine in gastrin-deficient mouse. Dig Dis Sci (2003) 0.87
Gastrins, iron homeostasis and colorectal cancer. Biochim Biophys Acta (2011) 0.86
The role of the gastrointestinal tract in calcium homeostasis and bone remodeling. Osteoporos Int (2013) 0.85
Stomaching calcium for bone health. Nat Med (2009) 0.84
Mouse models of gastric carcinogenesis. J Gastric Cancer (2014) 0.84
Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention. Neuropsychopharmacology (2014) 0.83
Genetic dissection of the signaling pathways that control gastric acid secretion. Inflammopharmacology (2005) 0.81
Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo. Am J Pathol (2004) 0.80
Gastrin-deficient mice have disturbed hematopoiesis in response to iron deficiency. Endocrinology (2011) 0.79
Identification of a series of CCK-2 receptor nonpeptide agonists: sensitivity to stereochemistry and a receptor point mutation. Proc Natl Acad Sci U S A (2003) 0.79
Cholecystokinin: an excitatory modulator of mitral/tufted cells in the mouse olfactory bulb. PLoS One (2013) 0.77
Abnormal gastric morphology and function in CCK-B/gastrin receptor-deficient mice. Yale J Biol Med (1999) 0.76
Hypochlorhydria-induced calcium malabsorption does not affect fracture healing but increases post-traumatic bone loss in the intact skeleton. J Orthop Res (2016) 0.76
Functional synergy between cholecystokinin receptors CCKAR and CCKBR in mammalian brain development. PLoS One (2015) 0.75
Enhanced reduction of Helicobacter pylori load in precolonized mice treated with combined famotidine and urease-binding polysaccharides. Antimicrob Agents Chemother (2000) 0.75
Ontogeny of ECL cells in the rat. Yale J Biol Med (1999) 0.75
Osteopetrorickets due to Snx10 deficiency in mice results from both failed osteoclast activity and loss of gastric acid-dependent calcium absorption. PLoS Genet (2015) 0.75
Dissecting carboxypeptidase E: properties, functions and pathophysiological roles in disease. Endocr Connect (2017) 0.75
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med (1997) 4.11
Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J Virol (1990) 2.95
Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg (1986) 2.72
A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J Virol (1989) 2.72
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest (1972) 2.39
Molecular cloning of human gastrin cDNA: evidence for evolution of gastrin by gene duplication. Proc Natl Acad Sci U S A (1983) 2.35
Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol (1973) 2.12
Preparation of 125 I-labelled synthetic human gastrin I for radioimmunoanalysis. Scand J Clin Lab Invest (1972) 2.07
[Molecular biology]. Ugeskr Laeger (2000) 2.02
[Back pain--time for a little science?]. Ugeskr Laeger (1998) 2.02
Does warm-up using mental practice improve crisis resource management performance? A simulation study. Br J Anaesth (2012) 2.02
Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem (1978) 1.99
Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. Gut (1973) 1.97
Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet (1977) 1.81
Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab (2006) 1.81
Increased cardiac BNP expression associated with myocardial ischemia. FASEB J (2003) 1.78
Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci U S A (1992) 1.77
Femoral vessel depth and the implications for groin node radiation. Int J Radiat Oncol Biol Phys (1993) 1.75
Somatostatin cell processes as pathways for paracrine secretion. Science (1979) 1.69
Immunoreactive gastrin components in human serum. Gut (1974) 1.65
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem (1978) 1.62
Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with the argyrophil component of secretory granules. Histochemistry (1986) 1.58
Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation. Genes Dev (1994) 1.58
Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet (1976) 1.56
Laser resurfacing-induced hypopigmentation: histologic alterations and repigmentation with topical photochemotherapy. Dermatol Surg (2001) 1.51
Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res (1979) 1.49
Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology (1997) 1.45
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J Clin Invest (1999) 1.45
Negative regulation of T-cell adhesion and activation by CD43. Nature (1995) 1.44
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg (2012) 1.42
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Angiographic architecture of intracranial vascular malformations and fistulas--pretherapeutic aspects. Neurosurg Rev (1986) 1.40
Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 1.39
Neuropeptides and neural cell adhesion molecule (NCAM) in CSF from patients with ALS. Acta Neurol Scand (1989) 1.39
[On back training in low back pain]. Ugeskr Laeger (1993) 1.39
Targeted disruption of CD43 gene enhances T lymphocyte adhesion. J Immunol (1993) 1.37
Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology (1993) 1.37
TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site. J Immunol (1998) 1.37
Negative regulation of T cell homing by CD43. Immunity (1998) 1.36
Release of gastrin by epinephrine in man. Gastroenterology (1973) 1.35
A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature (1993) 1.34
Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol (1998) 1.33
Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice. Cancer Lett (1992) 1.32
Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.30
Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity. J Physiol (1974) 1.27
The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem (1993) 1.27
Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature (1980) 1.24
New consensus features for tyrosine O-sulfation determined by mutational analysis. J Biol Chem (1997) 1.23
Structure of a human gastrin gene. Proc Natl Acad Sci U S A (1984) 1.23
Regulation of cation content and cell volume in hemoglobin erythrocytes from patients with homozygous hemoglobin C disease. J Clin Invest (1985) 1.22
High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res (2001) 1.20
The lateral spinal artery of the upper cervical spinal cord. Anatomy, normal variations, and angiographic aspects. J Neurosurg (1985) 1.20
Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. J Physiol (1977) 1.20
Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch (1996) 1.19
Localisation of gastrins to neuro- and adenohypophysis. Nature (1978) 1.19
The role of dural anomalies in vein of Galen aneurysms: report of six cases and review of the literature. AJNR Am J Neuroradiol (1987) 1.17
Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology (2003) 1.16
Identification of a transcriptional enhancer important for enteroendocrine and pancreatic islet cell-specific expression of the secretin gene. Mol Cell Biol (1992) 1.16
The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest (1973) 1.16
Measurement of direct photon production in p+p collisions at sqrt[s] = 200 GeV. Phys Rev Lett (2007) 1.16
Gastric carcinoids and related endocrine growths. Digestion (1986) 1.15
Gastrins in tissue. Concentration and component pattern in gastric, duodenal, and jejunal mucosa of normal human subjects and patients with duodenal ulcer. Gastroenterology (1976) 1.15
Gastrin and colorectal cancer: a never-ending dispute? Gastroenterology (1995) 1.14
A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing. Neuroscience (1980) 1.14
Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol (2007) 1.14
Evidence for a common evolutionary origin of gastrin and cholecystokinin. Nature (1977) 1.13
Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein. Biochem Biophys Res Commun (1994) 1.13
Acute myocardial hypoxia increases BNP gene expression. FASEB J (2004) 1.12
Effect of metiamide, a histamine H2-receptor antagonist, on mucosal blood flow and serum gastrin level. Gastroenterology (1974) 1.12
Heptadecapeptide gastrin in the vagal nerve. Proc Natl Acad Sci U S A (1977) 1.11
Pancreatic gastrin in foetal and neonatal rats. Nature (1976) 1.10
Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association. Am J Surg Pathol (1990) 1.10
Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair. Osteoarthritis Cartilage (2006) 1.10
Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass. Int J Obes (Lond) (2013) 1.10
Radioimmunoassay of cholecystokinin in human plasma. Clin Chim Acta (1981) 1.09
Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol (2004) 1.09
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology (2016) 1.09
Gastric endocrine cells: types, function and growth. Regul Pept (2000) 1.09
Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK. Am J Physiol (1999) 1.08
Parallel sets of autoantibodies in MRL-lpr/lpr mice. An anti-DNA, anti-SmRNP, anti-gp70 network. J Exp Med (1987) 1.08
Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia. J Clin Invest (1976) 1.08
Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function. Am J Physiol Gastrointest Liver Physiol (2006) 1.07
Four basic characteristics of the gastrin-cholecystokinin system. Am J Physiol (1981) 1.07
Distinct patterns of chronic gastritis associated with carcinoid and cancer and their role in tumorigenesis. Yale J Biol Med (1994) 1.07
Gastrin response to insulin after selective, highly selective, and truncal vagotomy. Gastroenterology (1974) 1.06
A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43. J Exp Med (2000) 1.05
Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature (1980) 1.05
Gastrins in serum. A review of gastrin radioimmunoanalysis and the discovery of gastrin heterogeneity in serum. Scand J Gastroenterol (1973) 1.04
Complete tyrosine-O-sulphation of gastrin in neonatal rat pancreas. Nature (1984) 1.04
Thiamine uptake in human intestinal biopsy specimens, including observations from a patient with acute thiamine deficiency. Am J Clin Nutr (1997) 1.03
Occurrence and neonatal development of gastrin immunoreactivity in the digestive tract of the rat. Cell Tissue Res (1974) 1.03
Studies in transgenic mice reveal potential relationships between secretin-producing cells and other endocrine cell types. J Biol Chem (1995) 1.03
Mixed endocrine gastric tumors associated with hypergastrinemia of antral origin. Am J Pathol (1978) 1.02
Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. Am J Physiol Gastrointest Liver Physiol (2001) 1.02